A dispute over a common asthma drug leaves patients caught in the middle : vimarsana.com

The most common asthma inhaler for children was discontinued at the start of this year, forcing parents and pediatricians to scramble to switch to an alternative. But more than a month later, the situation has not improved, and families remain caught in the middle of a fight between a drug company and pharmacy benefit managers…

Related Keywords

Massachusetts , United States , Boston , Ben Nelson , Christy Sadreameli , Shilpa Patel , William Feldman , Robyn Cohen , Children National Hospital , Boston Medical Center , Drug Administration , Boston Medical Center Cohen , Harvard Medical School , Express Scripts , Boston Medical , National Hospital , Massachusetts General Hospital , Johns Hopkins , Asthma Inhaler , Rug Company , Authorized Generic , Pediatric Pulmonologist , Eneric Versions , Lovent Hfa , Rug Costs , Edicaid , Vs Caremark , Sthma , Xpress Scripts ,